Forward Pharma A/S

Share · US34986J3032 (OTC)

No Price

n/a

Company Profile for Forward Pharma A/S Share

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

AI Analysis of Forward Pharma A/S

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Forward Pharma A/S

No AI threads available for this company yet.

Company Data

Name Forward Pharma A/S

Company Forward Pharma A/S

Website https://www.forward-pharma.com

Primary Exchange

UTC

ISIN US34986J3032

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Claus Bo Søndergaard Svendsen

Country Denmark

Currency USD

Employees 0,0 T

Address Oestergade 24A, 1100 Copenhagen

IPO Date 2014-10-15

Ticker Symbols

Name	Symbol
Over The Counter	FWPAY

More Shares

Investors who hold Forward Pharma A/S also have the following shares in their portfolio:

Hallmark Venture Group, Inc. Share

Janus Henderson Adaptive Risk Managed U.S. Equity-Asset Fund - T Shares Fund

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog